We are Particle3D
Particle3D is a Danish medical technology company working to make bone replacements more accurate, effective and safe.
In 2014, two engineering students and their professor invented the revolutionary technology as a solution to a problem. The then head of the unit for Oral and Maxillofacial Surgery at Odense University Hospital asked them to investigate a solution for replacing destroyed or surgically removed bone that could surpass all conventional treatments offered. He asked for a material that is easily moldable, slowly degradable and natural to the human body, allowing surgeons to restore the patient’s tissue to its former shape and composition.
Meet the Particle3D Team
The Company is driven by a strong team of ambitious, innovative and talented people who have extensive experience within life science, technology and business development.
Learn more about how We Print Bone™ and the clinical benefits of our P3D Bone.
I am very pleased to see the development and execution of our corporate strategy advancing. In addition to the company’s finalization of the development and registration of the innovative 3D printed customized bone implants, we intend to devote significant time and effort to pursuing global opportunities in offering 3D printed implants for different indications with the possibility of adding slowly released medication, such as antibiotics, which we belive offers tremendous opportunities for patients and health care providers.Thea Wulff Olesen
Latest News From Particle3D
Read about the latest news, interviews and events.
Particle3D ApSVestre Stationsvej 15, 15000 Odense C Denmark Press Release Particle3D raises capital through West Hill ODENSE, May 18th, 2020 – Particle3D, We Print Bone™, is pleased to announce that the £2.5 million capital raise through...
First step into the U.S. market Particle3D receives investment from New York based venture capital firm, Asimov Ventures, and enters valuable U.S. partnership. The partnership with Asimov Ventures marks the Company's first step into the U.S. market, looking toward an...
First Patent Approved Today, the European Patent Office announced that patent EP/3359318 for the Company's novel technology has been approved and published. The approval marks the first patent issuance which will be followed by continuations in parts originating from...